Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole

Neuroscience Letters

Volumn 446, Issue 2-3, 2008, Pages 101-104

  Beerepoot, Pieter ^a   Lam, Vincent ^a   Luu, Alice ^a   Tsoi, Bernice ^a   Siebert, Daniel ^b   Szechtman, Henry ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Salvia Divinorum Research and Information Center   (United States)

Author keywords

Bidirectional modulation; Locomotor sensitization; Quinpirole; Salvinorin A; U69593

Indexed keywords

DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; QUINPIROLE; SALVINORIN A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; STRUCTURE ACTIVITY RELATION;

ANALGESICS; ANIMALS; BENZENEACETAMIDES; CENTRAL NERVOUS SYSTEM; DITERPENES, CLERODANE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG RESISTANCE; DRUG SYNERGISM; MALE; MOTOR ACTIVITY; PYRROLIDINES; QUINPIROLE; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, KAPPA; SYNAPTIC TRANSMISSION;

EID: 53849146695     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.09.035     Document Type: Article

References (16)

1. Appel J., and Kim-Appel D. The rise of a new psychoactive agent: Salvia divinorum. Int. J. Ment. Health Addict. 5 (2008) 248-253
2. Chartoff E.H., Potter D., Damez-Werno D., Cohen B.M., and Carlezon Jr. W.A. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology 33 (2008) 2676-2687
3. Gonzalez D., Riba J., Bouso J.C., Gomez-Jarabo G., and Barbanoj M.J. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend. 85 (2006) 157-162
4. Haroz R., and Greenberg M.I. Emerging drugs of abuse. Med. Clin. North Am. 89 (2005) 1259-1276
5. Kane B.E., McCurdy C.R., and Ferguson D.M. Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor. J. Med. Chem. 51 (2008) 1824-1830
6. Ortega A., Blount J.F., and Manchand P.S. Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae). J. Chem. Soc., Perkin Trans. 1 (1982) 2505-2508
7. Perreault M.L., Graham D., Bisnaire L., Simms J., Hayton S., and Szechtman H. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms. Neuropsychopharmacology 31 (2006) 1967-1981
8. Perreault M.L., Graham D., Scattolon S., Wang Y., Szechtman H., and Foster J.A. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology (Berl.) 194 (2007) 485-496
9. Perreault M.L., Seeman P., and Szechtman H. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Behav. Neurosci. 121 (2007) 976-991
10. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., Ernsberger P., and Rothman R.B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11934-11939
11. Sheffler D.J., and Roth B.L. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol. Sci. 24 (2003) 107-109
12. Szechtman H., Talangbayan H., Canaran G., Dai H., and Eilam D. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism [published erratum appears in Psychopharmacology (Berl.) 1994 Sep;116(1):124]. Psychopharmacology (Berl.) 115 (1994) 95-104
13. Szumlinski K.K., Allan M., Talangbayan H., Tracey A., and Szechtman H. Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology (Berl.) 134 (1997) 193-200
14. Valdes L.J., Butler W.M., Hatfield G.M., Paul A.G., and Koreeda M. Divinorin-A, a psychotropic terpenoid, and divinorin-B from the hallucinogenic Mexican mint Salvia divinorum. J. Org. Chem. 49 (1984) 4716-4720
15. Wang Y., Tang K., Inan S., Siebert D., Holzgrabe U., Lee D.Y., Huang P., Li J.G., Cowan A., and Liu-Chen L.Y. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J. Pharmacol. Exp. Ther. 312 (2005) 220-230
16. Wasson R.G. A New Mexican Psychotropic Drug from the Mint Family Botanical Museum Leaflets (1962), Harvard University, vol. 20 pp. 77-84